These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 31029916

  • 41. Long-Term Outcomes With Teduglutide From a Single Center.
    Puello F, Wall E, Herlitz J, Lozano ES, Semrad C, Micic D.
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
    [Abstract] [Full Text] [Related]

  • 42. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R.
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [Abstract] [Full Text] [Related]

  • 43. Results of 12-month rescue treatment with Teduglutide in severely active and parenteral nutrition-dependent Crohn's disease.
    Borghini R, Caronna R, Picarelli A, Corazziari ES.
    Turk J Gastroenterol; 2017 Jan; 28(1):73-74. PubMed ID: 27991856
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [Abstract] [Full Text] [Related]

  • 45. Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome.
    Wauters L, Vanuytsel T.
    Curr Opin Pharmacol; 2018 Dec; 43():118-123. PubMed ID: 30273889
    [Abstract] [Full Text] [Related]

  • 46. Teduglutide: a guide to its use in short bowel syndrome.
    McKeage K.
    Clin Drug Investig; 2015 May; 35(5):335-40. PubMed ID: 25859983
    [Abstract] [Full Text] [Related]

  • 47. Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Borghini R, Villanacci V, Oberti A, Caronna R, Trecca A.
    Inflamm Bowel Dis; 2021 Nov 15; 27(12):e152-e153. PubMed ID: 34255043
    [No Abstract] [Full Text] [Related]

  • 48. Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.
    Florencio Ojeda L, Domínguez Rabadán R, Laínez López M, Jaldón Hidalgo G, Rodríguez Andrés N, Penco Ramírez C, Rebollo Pérez MI.
    Nutrition; 2023 Sep 15; 113():112137. PubMed ID: 37481817
    [Abstract] [Full Text] [Related]

  • 49. [The treatment of hypomagnesemia].
    van der Sijs IH, Ho-Dac-Pannekeet MM.
    Ned Tijdschr Geneeskd; 2002 May 18; 146(20):934-8. PubMed ID: 12051060
    [Abstract] [Full Text] [Related]

  • 50. De Novo Development of Distal Jejunal and Duodenal Adenomas After 41 Months of Teduglutide Treatment in a Patient With Short-Bowel Syndrome: A Case Report.
    Pevny S, Pape UF, Elezkurtaj S, Rieger A, Jürgensen C, Blüthner E, Jochum C, Tacke F, Maasberg S.
    JPEN J Parenter Enteral Nutr; 2021 Mar 18; 45(3):652-656. PubMed ID: 32740933
    [Abstract] [Full Text] [Related]

  • 51. Renal magnesium wasting in a patient with short bowel syndrome with magnesium deficiency: effect of 1 alpha-hydroxyvitamin D3 treatment.
    Fukumoto S, Matsumoto T, Tanaka Y, Harada S, Ogata E.
    J Clin Endocrinol Metab; 1987 Dec 18; 65(6):1301-4. PubMed ID: 3680484
    [Abstract] [Full Text] [Related]

  • 52. Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects.
    Vipperla K, O'Keefe SJ.
    Expert Rev Gastroenterol Hepatol; 2013 Nov 18; 7(8):683-7. PubMed ID: 24134154
    [Abstract] [Full Text] [Related]

  • 53. Magnesium Disorders.
    Jacobs FM.
    N Engl J Med; 2024 Aug 15; 391(7):668. PubMed ID: 39141869
    [No Abstract] [Full Text] [Related]

  • 54. Magnesium Disorders.
    Gorard D.
    N Engl J Med; 2024 Aug 15; 391(7):668. PubMed ID: 39141870
    [No Abstract] [Full Text] [Related]

  • 55. A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
    Nomoto H, Miyoshi H, Nakamura A, Nagai S, Kitao N, Shimizu C, Atsumi T.
    Medicine (Baltimore); 2017 Sep 15; 96(39):e8147. PubMed ID: 28953654
    [Abstract] [Full Text] [Related]

  • 56. De Novo Development of Hamartomatous Duodenal Polyps in a Patient With Short Bowel Syndrome During Teduglutide Therapy: A Case Report.
    Ukleja A, Alkhairi B, Bejarano P, Podugu A.
    JPEN J Parenter Enteral Nutr; 2018 Mar 15; 42(3):658-660. PubMed ID: 28666089
    [Abstract] [Full Text] [Related]

  • 57. Managing fluid balance and nutritional status in a short bowel syndrome patient awaiting intestinal transplant: a case report.
    Bouloubasi Z, Karayiannis D, Papadopoulou A, Dimitrokallis N, Tsanasa A, Karveli E, Vougas V.
    Eur J Clin Nutr; 2024 May 15; 78(5):455-458. PubMed ID: 38267532
    [Abstract] [Full Text] [Related]

  • 58. Magnesium Disorders.
    Manger B, Schett G.
    N Engl J Med; 2024 Aug 15; 391(7):668-669. PubMed ID: 39141871
    [No Abstract] [Full Text] [Related]

  • 59. Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.
    George AT, Di Cocco P, Benedetti E, Boulay BR, Carroll RE.
    JPEN J Parenter Enteral Nutr; 2021 May 15; 45(4):839-843. PubMed ID: 32829492
    [No Abstract] [Full Text] [Related]

  • 60. Teduglutide for the treatment of short bowel syndrome.
    Ferrone M, Scolapio JS.
    Ann Pharmacother; 2006 Jun 15; 40(6):1105-9. PubMed ID: 16705029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.